<DOC>
	<DOCNO>NCT01400958</DOCNO>
	<brief_summary>The purpose study determine Nuvigil® improve fatigue experienced people receive external beam radiation therapy treatment malignant glioma . It also do determine Nuvigil® improve cognitive function ( perception , thinking , reason , remember ) overall quality life people receive external beam radiation therapy treatment malignant glioma . Another purpose study see people receive Nuvigil® less side effect people receive placebo . Placebo substance look like active drug active ingredient .</brief_summary>
	<brief_title>Nuvigil Placebo Newly Diagnosed Malignant Glioma</brief_title>
	<detailed_description>Study visit time correspond standard follow-up evaluation patient 's malignant glioma . Study visit occur baseline ( Week 0 ) ; Week 7 , patient stop use study drug first round external beam radiation therapy temozolomide ; Weeks 10 , 18 , 34 . The Week 7 evaluation include : neuropsychological exam , Psychosocial Questionnaires , question patient 's medication health . The Week 10 18 evaluation include : vital sign measurement , Karnofsky Performance status rating , neurological neuropsychological exam , psychosocial questionnaire , Magnetic Resonance Imaging ( MRI ) patient 's brain , question medication health . The Week 34 evaluation include : vital sign measurement , Karnofsky Performance status rating , neurological neuropsychological exam , psychosocial questionnaire , question patient 's medication health .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<criteria>Ages 18 year great study entry Histologic diagnosis supratentorial World Health Organization ( WHO ) grade 3 anaplastic glioma ( include astrocytoma , oligodendroglioma , mixed oligoastrocytoma ) WHO grade 4 glioblastoma require external beam radiation therapy ( EBRT ) concurrent temozolomide ( TMZ ) Have adequate renal liver function evidence follow screen lab value : Creatinine ≤ 1.7mg/dl ; Total Bilirubin ≤ 1.5mg/dl ; Transaminases ≤ 4 time upper normal limit ; Prothrombin time/international normalize ratio ( PT/INR ) &lt; 1.4 patient warfarin Adequate bone marrow function define follow lab value : Absolute neutrophil count ( ANC ) ≥ 1,500/mm³ ; Platelets ≥ 100,000 cells/mm³ ; Hemoglobin ≥ 10.0 gm/dL ; White blood cell count ( WBC ) ≥ 3,000/mcL Karnofsky Performance Status ≥ 60 % Recovered immediate neurosurgical postoperative period ( e.g . craniotomy , least 2 week period time allow wound heal ) Agrees use acceptable birth control method ( ) . Females use steroidal contraception ( oral , depot , implantable ) must agree use alternative concomitant method contraception throughout therapy well one month discontinuation therapy . Agrees avoid alcohol consumption therapy Preexisting document traumatic brain injury Preexisting dementing illness due degenerative , cerebrovascular , static progressive neurologic process Neurological deficit hemineglect homonymous hemianopsia baseline neurologic examination would preclude effective participation cognitive test Intracranial space occupy lesion malignant glioma benign asymptomatic meningioma Prior treatment EBRT stereotactic radiosurgery ( SRS ) brain Prior treatment Nuvigil® Provigil® within 4 week prior study entry Leptomeningeal disease suggest clinically radiographic criterion History leave ventricular cardiac hypertrophy Ischemic ECG change , chest pain , arrhythmia , clinically significant manifestation mitral valve prolapse association central nervous system ( CNS ) stimulant use within past 6 month Unstable angina myocardial infarction within past 6 month Premorbid ongoing psychosis Currently receive Ritalin Tricyclic Antidepressants . Nuvigil demonstrate affect serum level Triazolam Cyclosporine . Patients take medication monitor potential dose adjustment . Other medication metabolize cytochrome P450 pathway may potentially affect , demonstrated clinical test . Such medication monitor throughout study possible dose adjustment . Patients experience significant fatigue secondary medical physiologic cause primarily malignant glioma Pregnant , breastfeeding , lack willingness use recommend birth control method Patients know hypersensitivity modafinil , armodafinil , inactive ingredient Patients unable understand comply condition protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>fatigue</keyword>
	<keyword>external beam radiation</keyword>
	<keyword>EBRT</keyword>
	<keyword>radiation therapy</keyword>
	<keyword>placebo</keyword>
	<keyword>cognitive function</keyword>
	<keyword>TMZ</keyword>
	<keyword>Temozolomide</keyword>
</DOC>